Filtered By:
Source: Arthritis Care and Research
Condition: Arthritis
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 26 results found since Jan 2013.
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population ‐Based Study
Conclusion: Patients with SLE have an increased risk of cardiovascular events, particularly during the first year after diagnosis. Increased vigilance in monitoring for these potentially fatal outcomes and their modifiable risk factors is recommended in this patient population. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - January 26, 2017 Category: Rheumatology Authors: J. Antonio Avi ña‐Zubieta, Fergus To, Kateryna Vostretsova, Mary De Vera, Eric C. Sayre, John M. Esdaile Tags: Original Article Source Type: research
High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener’s)
Conclusion: The present study confirms that GPA patients have a markedly increased risk of venous thromboembolism. We did not observe an increased risk of stroke in our cohort. Thus, our observations demonstrate a differential impact of GPA and/or its treatment on the risk of various vascular events. © 2014 American College of Rheumatology.
Source: Arthritis Care and Research - July 29, 2014 Category: Rheumatology Authors: Mikkel Faurschou, Niels Obel, Bo Baslund Tags: Original Article Source Type: research
The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis
Conclusion: It is difficult to determine the frequency of a “clinically significant aPL profile” in patients with aPL‐related clinical outcomes due to the lack of robust data. Our best estimates of the incidence of aPL‐associated events should be confirmed with appropriately designed population studies. © 2013 American College of Rheumatology.
Source: Arthritis Care and Research - July 16, 2013 Category: Rheumatology Authors: Laura Andreoli, Cecilia B. Chighizola, Alessandra Banzato, Guillermo J. Pons‐Estel, Guilherme Ramires de Jesus, Doruk Erkan, Tags: Brief Report Source Type: research
Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
ConclusionIt is difficult to determine the frequency of a “clinically significant aPL profile” in patients with aPL‐related clinical outcomes due to the lack of robust data. Our best estimates of the incidence of aPL‐associated events should be confirmed with appropriately designed population studies.
Source: Arthritis Care and Research - October 28, 2013 Category: Rheumatology Authors: Laura Andreoli, Cecilia B. Chighizola, Alessandra Banzato, Guillermo J. Pons‐Estel, Guilherme Ramire Jesus, Doruk Erkan, Tags: Brief Reports Source Type: research
The burden of co‐morbidity in Systemic Lupus Erythematosus in the United Kingdom 1999‐2012
Conclusions: People with SLE in the UK have a greater burden of co‐morbidity and are more likely to develop CVD, stroke, ESRF, cancer, osteoporosis and infection than people of the same age and gender. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - October 16, 2015 Category: Rheumatology Authors: Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport, Weiya Zhang Tags: Original Article Source Type: research
Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999–2012
ConclusionPeople with SLE in the UK have a greater burden of comorbidity and are more likely to develop CVD, stroke, ESRF, cancer, osteoporosis, and infection than people of the same age and sex.
Source: Arthritis Care and Research - May 25, 2016 Category: Rheumatology Authors: Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport, Weiya Zhang Tags: Systemic Lupus Erythematosus Source Type: research
Cerebrovascular Events in Systemic Lupus Erythematosus
ConclusionCerVEs, the fourth most frequent NP event in SLE, are usually attributable to lupus. In contrast to good physician reported outcomes, patients report a sustained reduction in health‐related quality of life following CerVEs.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - January 5, 2018 Category: Rheumatology Authors: John G. Hanly, Qiuju Li, Li Su, Murray B. Urowitz, Caroline Gordon, Sang ‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Sasha Bernatsky, Ann E. Clarke, Daniel J Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul Fortin, Dafna Tags: Original Article Source Type: research
Does renin‐angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case‐control study
Conclusions: Our data do not support the hypothesis that ACEIs/ARBs may be protective against atherosclerotic CVEs in LN patients. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - February 11, 2016 Category: Rheumatology Authors: Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray B Urowitz Tags: Original Article Source Type: research
Rheumatoid Factors Are Associated with Subclinical and Clinical Atherosclerosis in African American Women: The Multi‐Ethnic Study of Atherosclerosis (MESA)
Conclusion. RA‐related autoantibodies are associated with subclinical and clinical atherosclerosis in AA women from a community based non‐RA cohort indicating autoimmune factors may play a role in the pathogenesis of atherosclerosis. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - May 8, 2016 Category: Rheumatology Authors: Darcy S. Majka, Thanh‐Huyen T. Vu, Richard M. Pope, Marius Teodorescu, Elizabeth W. Karlson, Kiang Liu, Rowland W. Chang Tags: Original Article Source Type: research
Does Renin ‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study
ConclusionOur data do not support the hypothesis that ACE inhibitors/ARBs may be protective against atherosclerotic CVEs in LN patients.
Source: Arthritis Care and Research - August 18, 2016 Category: Rheumatology Authors: Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz Tags: Original Article Source Type: research
Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis
ConclusionRA‐related autoantibodies are associated with subclinical and clinical atherosclerosis in African American women from a community‐based non‐RA cohort, indicating autoimmune factors may play a role in the pathogenesis of atherosclerosis.
Source: Arthritis Care and Research - January 26, 2017 Category: Rheumatology Authors: Darcy S. Majka, Thanh ‐Huyen T. Vu, Richard M. Pope, Marius Teodorescu, Elizabeth W. Karlson, Kiang Liu, Rowland W. Chang Tags: Rheumatoid Arthritis Source Type: research
Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes?
ConclusionFindings from the present study suggest that while CVD risk in RA is elevated, it is lower in magnitude compared to the CVD risk associated with diabetes. It therefore may not be appropriate to consider RA a diabetes risk‐equivalent with respect to hyperlipidemia management.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - February 6, 2018 Category: Rheumatology Authors: Jeffrey R Curtis, Shuo Yang, Jasvinder A. Singh, Fenglong Xie, Lang Chen, Huifeng Yun, Paul Muntner, Shia T Kent, Emily B. Levitan, Monika M. Safford, Kenneth G. Saag, Jie Zhang Tags: Brief Report Source Type: research
Systemic lupus erythematosus is associated with a higher risk of cervical but not trochanteric hip fracture: A nationwide population‐based study
Conclusion:Patients with SLE are associated with a higher risk for cervical but not trochanteric HF and these two HFs have different risk factors. © 2013 by the American College of Rheumatology
Source: Arthritis Care and Research - April 16, 2013 Category: Rheumatology Authors: Shu‐Hung Wang, Yu‐Sheng Chang, Chia‐Jen Liu, Chien‐Chih Lai, Wei‐Sheng Chen, Tzeng‐Ji Chen, Shuu‐Jiun Wang Tags: Original Article Source Type: research
TNF‐α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis patients
Conclusion: Use of TNF‐α inhibitors is associated with a decreased risk for CAD in RA; the risk decreases further with longterm use. This should be considered when weighing the risks versus benefits of these medications. © 2013 American College of Rheumatology.
Source: Arthritis Care and Research - September 10, 2013 Category: Rheumatology Authors: Androniki Bili, Xiaoqin Tang, Shruthi Pranesh, Rasa Bozaite, Stephanie J. Morris DO, Jana L. Antohe, H. Lester Kirchner, Mary Chester M. Wasko Tags: Original Article Source Type: research
Association of Systemic Lupus Erythematosus With a Higher Risk of Cervical but Not Trochanteric Hip Fracture: A Nationwide Population‐Based Study
ConclusionSLE is associated with a higher risk for cervical but not trochanteric HF, and these 2 types of HFs have different risk factors.
Source: Arthritis Care and Research - September 24, 2013 Category: Rheumatology Authors: Shu‐Hung Wang, Yu‐Sheng Chang, Chia‐Jen Liu, Chien‐Chih Lai, Wei‐Sheng Chen, Tzeng‐Ji Chen, Shuu‐Jiun Wang Tags: Systemic Lupus Erythematosus Source Type: research
